HAE
Haemonetics Corp Health Care Surgical & Medical Instruments & Apparatus Russell 3000
$119.65Close
$5.4BMarket cap
$49.99 – $122.0652-week range
Nov 5, 2026Next report · before the open
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 97 · stronger than 97% of stocks over 12 months
- RS line at a 1-year high outperforming the S&P 500 more than at any point this year
- Near its high 2% below its 52-week high
Cautions
- Results soon Nov 5, 2026, in 4 days
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
2%
1wk
up 1.0%
price change
1mo
up 13.6%
price change
12-month return
up 139%
market up 11% ·
its own up 131%
F-score
6 / 9
Mixed
Altman Z
3.24
Low risk
P/E
55642.7×
price / earnings
PEG
—
P/E / EPS growth
P/B
6.8×
price / book
Earnings yield
up 2.5%
EBIT / enterprise value
Cheaper than
43%
of the market · around average
Revenue growth
down 2%
year on year
EPS growth
up 3%
latest quarter
Sales growth
up 6%
latest quarter · +1 pts
ROE
0%
return on equity
Free cash margin
up 20%
$260.4M FCF
D/E
1.53
long-term debt / equity
Net debt / EBITDA
3.6×
Interest cover
8.1×EBIT / interest
Piotroski tests
- profitability slipped from last year
- took on more long-term debt
- assets working less efficiently
- profitable on its assets
- generating cash from operations
- profits backed by cash
- short-term liquidity improved
- no new shares issued
- gross margin widened
Repair signals
- Gross margin 55.0% → 59.0%
Trade setup
ATR%
2.7%
$3.28 a day · 2×ATR $113.09
RS
97 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
0.7×
vs 50-day average
Up/down volume
0.93
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Revenue shrinking Revenue fell 2.0% over the year, from $1.4B to $1.3B.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026+5% vs market2 sessions after results
Financials
- Gross 59%
- Net 0%
- Free cash 20%
- Cash
- Long-term debt
| FY2021Apr 3, 2021 | FY2022Apr 2, 2022 | FY2023Apr 1, 2023 | FY2024Mar 30, 2024 | FY2025Mar 29, 2025 | FY2026Mar 28, 2026 | |
|---|---|---|---|---|---|---|
| Revenue | $870.5M | $993.2M | $1.2B | $1.3B | $1.4B | $1.3B |
| Gross margin | 46% | 51% | 53% | 53% | 55% | 59% |
| Operating income | $89.7M | $80.8M | $156.0M | $164.9M | $221.8M | $156.7M |
| Net income | $79.5M | $43.4M | $115.4M | $117.6M | $167,679 | $97,308 |
| Net margin | 9% | 4% | 10% | 9% | 0% | 0% |
| Earnings per share | $1.55 | $0.84 | $2.24 | $2.29 | $0.00 | $0.00 |
| Free cash flow | $71.8M | $75.8M | $81.7M | $143.6M | $142.4M | $260.4M |
| Free cash margin | 8% | 8% | 7% | 11% | 10% | 20% |
| Cash | $192.3M | $259.5M | $284.5M | $178.8M | $306.8M | $245.4M |
| Long-term debt | $690.6M | $559.4M | $754.1M | $797.6M | $921.2M | $1.2B |
| Shareholders' equity | $731.7M | $749.4M | $818.0M | $960.0M | $820.8M | $796.3M |
| Shares outstanding | 50.87m | 51.12m | 50.45m | 50.79m | 48.22m | 45.25m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 27, 2026 | 40d |
| May 20, 2026 | Annual ↗ | Mar 28, 2026 | 53d |
| Feb 5, 2026 | Quarterly ↗ | Dec 27, 2025 | 40d |
| Nov 6, 2025 | Quarterly ↗ | Sep 27, 2025 | 40d |
| Aug 7, 2025 | Quarterly ↗ | Jun 28, 2025 | 40d |
| May 21, 2025 | Annual ↗ | Mar 29, 2025 | 53d |
| Feb 6, 2025 | Quarterly ↗ | Dec 28, 2024 | 40d |
| Nov 7, 2024 | Quarterly ↗ | Sep 28, 2024 | 40d |
| Aug 8, 2024 | Quarterly ↗ | Jun 29, 2024 | 40d |
| May 20, 2024 | Annual ↗ | Mar 30, 2024 | 51d |
| Feb 8, 2024 | Quarterly ↗ | Dec 30, 2023 | 40d |
| Nov 2, 2023 | Quarterly ↗ | Sep 30, 2023 | 33d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 8, 2026 | Regulation FD ↗ |
| Aug 18, 2026 | Regulation FD ↗ |
| Aug 6, 2026 | Results ↗ |
| Jul 28, 2026 | Director or officer change · Shareholder vote ↗ |
| Jun 5, 2026 | Regulation FD ↗ |
| May 7, 2026 | Results ↗ |
| May 1, 2026 | Director or officer change ↗ |
| Mar 3, 2026 | Regulation FD ↗ |
| Feb 12, 2026 | Regulation FD ↗ |
| Feb 5, 2026 | Results ↗ |
| Jan 9, 2026 | Other events ↗ |
| Nov 6, 2025 | Results ↗ |